Comparator pH study to evaluate the single-dose pharmacodynamics of dual delayed-release dexlansoprazole 60 mg and delayed-release esomeprazole 40 mg

BACKGROUND: This paper describes a Phase 1, single-center, randomized, open-label, two-period crossover study which compared the pharmacodynamic effects of single doses of dexlansoprazole modified-release 60 mg and esomeprazole 40 mg on 24-hour intragastric pH in healthy adult subjects. METHODS: For...

Descripción completa

Detalles Bibliográficos
Autores principales: Kukulka, Michael, Eisenberg, Corey, Nudurupati, Sai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190289/
https://www.ncbi.nlm.nih.gov/pubmed/22016582
http://dx.doi.org/10.2147/CEG.S24063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190289/
https://www.ncbi.nlm.nih.gov/pubmed/22016582
http://dx.doi.org/10.2147/CEG.S24063

Ejemplares similares